This study is exploring if a clinical trial for idiopathic pulmonary fibrosis (IPF) can successfully recruit and keep participants who complete study tasks from home. Researchers want to see if a combination of zinc and nicotinamide riboside can help treat IPF. You would be compared to others receiving placebos (look-alike substances without active ingredients) to see if these supplements improve symptoms or lung function. The main goal is to learn if it's possible to run this type of study remotely and if participants with IPF might experience better symptoms, quality of life, or daily functioning by taking these supplements. The study is currently unclear on its recruitment status.

Study design

This is an interventional study planning to enroll 60 participants. It compares zinc and nicotinamide riboside to matched placebos.

What's involved

You would need to be available for the duration of the study and complete study procedures at your local clinical facilities.

Compensation

Not stated in the trial record.

Follow-up

The study measures feasibility of retention from study activation to 78 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.